New mesalazine formulation advantageous in IBD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1286, 2001-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review: New Anti-Cytokines for IBD: What is in the Pipeline?

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1405-1420

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Absorption Patterns of Mesalazine from Two Gastroresistant Tablets in Healthy Male Volunteers: Effects of Food and Formulation

By Vree T.B.

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 295-305

Adis International

Access to resources Recommend Favorite

Mesalazine for diverticular disease of the colon – a new role for an old drug

By Tursi Antonio

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 69-74

Informa Healthcare

Access to resources Recommend Favorite

Aripiprazole advantageous in bipolar disorder

Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: New Mechanisms and Targets for IBD Therapy: Translational Gastroenterology Comes of Age)

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1377-1378

Bentham Science Publishers

Access to resources Recommend Favorite